Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peitushengjin is a traditional Chinese medicine (TCM) formulation used primarily in the management of rheumatoid arthritis and related conditions. It is typically administered as granules or decoctions and may be part of multi-herbal regimens such as "Peitushengjinjiedutongluo." The formula is based on TCM principles aimed at "nourishing the spleen and generating fluids," which are believed to help alleviate symptoms like dryness, fatigue, and joint pain associated with chronic inflammatory diseases. Its mechanism of action is not defined by modern pharmacology but rather by TCM theory; it may exert immunomodulatory or anti-inflammatory effects according to some clinical observations. There are ongoing clinical studies evaluating its efficacy for interstitial pneumonia secondary to rheumatoid arthritis[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Peitushengjin.